Department of Radiology and Nuclear Medicine, Cantonal hospital Schaffhausen, Schaffhausen; University of Lucerne, Department of Health Sciences and Medicine, Lucerne.
University of Lucerne, Department of Health Sciences and Medicine, Lucerne; St. Anna Breast Center, Hirslanden Klinik St. Anna, Lucerne, Lucerne, Switzerland.
ESMO Open. 2024 Oct;9(10):103712. doi: 10.1016/j.esmoop.2024.103712. Epub 2024 Sep 24.
Switzerland is one of the few remaining European countries without a uniform national breast cancer screening program. Most Swiss cantons have initiated mammography screening programs, with the notable exceptions of the cantons of central Switzerland. The aim of this study is to compare the TNM (tumor-node-metastasis) status in woman diagnosed with screen- and non-screen-detected breast cancers. We compare TNM of breast cancers of cantonal screening cantons (Or-SC) with organized mammographic screening and opportunistic-screening cantons (Op-SC) without organized mammographic screening.
We compared the TNM documented in cantons with organized screening (Or-SC) in the national cancer registry with those in the cantons of central Switzerland without organized screening (Op-SC) between 2014 and 2020. Since 2014, a total of 19 236 patients from Or-SC and 2282 from Op-SC with breast cancer were compared. Age groups were defined as younger than 50 years, between 50 and 69 years, and older than 70 years.
By comparison, women aged 50-69 years in the cantons of the Op-SC group exhibited significantly larger tumors T1-3 [point estimate of the difference with 95% confidence interval (CI) for T1: -7.7% (95% CI -11.0% to -4.4%); T2: 5.3% (95% CI 2.2% to 8.5%); T3: 2.5% (95% CI 0.8% to 4.2%)] and significantly fewer proportion of N0 [-5.7% (95% CI -9.0% to -2.5%)] without significant difference in the M status (P = 0.97).
Our study shows that patients aged 50-69 years from Op-SC have significantly larger tumors and higher incidence of lymph node metastases than women in the corresponding Or-SC group. This globally unique case within one single small country with very high living standards, but with different screening strategies, indicates the benefits of organized breast screening programs.
瑞士是少数几个没有统一国家乳腺癌筛查计划的欧洲国家之一。大多数瑞士州都启动了乳房 X 光筛查计划,但瑞士中部的几个州除外。本研究的目的是比较经筛查和非筛查发现的乳腺癌患者的 TNM(肿瘤-淋巴结-转移)分期。我们比较了有组织的乳房 X 光筛查州(Or-SC)和没有组织的乳房 X 光筛查机会筛查州(Op-SC)的乳腺癌的 TNM。
我们比较了国家癌症登记处记录的有组织筛查(Or-SC)的州与 2014 年至 2020 年期间没有组织筛查(Op-SC)的瑞士中部各州的 TNM。自 2014 年以来,共比较了来自 Or-SC 的 19236 例和来自 Op-SC 的 2282 例乳腺癌患者。年龄组定义为 50 岁以下、50-69 岁和 70 岁以上。
相比之下,Op-SC 组中 50-69 岁的女性 T1-3 肿瘤明显更大[差异点估计值和 95%置信区间(CI)为 T1:-7.7%(95% CI-11.0%至-4.4%);T2:5.3%(95% CI 2.2%至 8.5%);T3:2.5%(95% CI 0.8%至 4.2%)],且 N0 比例明显更低[-5.7%(95% CI-9.0%至-2.5%)],但 M 状态无显著差异(P=0.97)。
我们的研究表明,Op-SC 中 50-69 岁的患者的肿瘤明显更大,淋巴结转移的发生率更高,而对应 Or-SC 组的女性则没有。在一个生活水平非常高但筛查策略不同的单一小国家中,这种情况在全球范围内是独一无二的,这表明了有组织的乳房筛查计划的益处。